AMY PRICE: Open Payments
NPI 1760161459 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,797 in 134 payments from 35 companies in 2025. Trend: 2023 $1,176 · 2024 $3,873 · 2025 $2,797
Food & beverage: $2,797
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $274 |
| Corcept Therapeutics | 16 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $156 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $152 |
| Astellas Pharma US Inc | 6 | $151 |
| Antares Pharma, Inc. | 7 | $148 |
| Medtronic, Inc. | 5 | $147 |
| Amgen Inc. | 10 | $144 |
| Ascendis Pharma Endocrinology Inc | 6 | $129 |
| Xeris Pharmaceuticals, Inc. | 6 | $124 |
Products named: Korlym, Ozempic, Kerendia, ISTURISA, Veozah, XYOSTED, Yorvipath, EVENITY.
Industry payments across FL — which companies pay providers there.
